68Ga PSMA PET/MR in the differentiation of low and high grade gliomas: Is 68Ga PSMA PET/MRI useful to detect brain gliomas?

被引:14
|
作者
Akgun, Elife [1 ]
Akgun, Mehmet Yigit [2 ]
Selcuk, Hatem Hakan [3 ]
Uzan, Mustafa [4 ]
Sayman, Haluk Burcak [5 ]
机构
[1] High Specialized Hosp, Dept Nucl Med, Kirikkale, Turkey
[2] High Specialized Hosp, Dept Neurosurg, Kirikkale, Turkey
[3] Dr Sadi Konuk Training & Res Hosp, Dept Radiol, Istanbul, Turkey
[4] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey
[5] Istanbul Univ Cerrahpasa, Cerrahpasa Med Fac, Dept Nucl Med, Istanbul, Turkey
关键词
Glial tumor; Grade(68)Ga PSMA; PET/MR;
D O I
10.1016/j.ejrad.2020.109199
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Magnetic resonance imaging (MRI) is the most important imaging modality in the diagnosis and follow-up of glial brain tumors. Objective: The aim of our study is to determine the correlation between tumor grade, determined with postoperative pathological examination, and standard uptake value (SUV), a semi-quantitative parameter, in patients who underwent imaging Ga-68-PSMA with using PET/MR. Material-method: Thirty-five out of 38 patients' images whose pathology was consistent with glial tumor, 42 lesions from separate anatomic localizations or with higher activity uptake than the rest of the tumor were evaluated. SUV values measured on PET images and grade relationship were evaluated based on each lesion while mitosis, Ki-67 were evaluated for each patient. Results: Grade, Ki-67, mitosis, necrosis and SUVmax/mean/peak were found statistically significant with moderate/high correlation. The parameter with the highest correlation coefficient was mitosis. (For SUVmax r = 0.64, p = 0). When Grade II and III were considered as the first group and IV as the second group, the cutoff values were found to be 2.3 for SUVmax, 0.21 for SUVmean and 0.63 for SUVpeak. In the diagnosis of HGG, PET's sensitivity is higher than MRI but no statistically difference was found between specificities. Conclusion: Ga-68 PSMA PET imaging is found to be particularly useful in differentiating Grade IV glial tumors from other grades. This finding is thought to be important in the differentiation the relapse with postoperative tissue changes, which is an important problem in the follow-up.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer
    Gao, Xiaomei
    Tang, Yongxiang
    Chen, Minfeng
    Li, Jian
    Yin, Hongling
    Gan, Yu
    Zu, Xiongbin
    Cai, Yi
    Hu, Shuo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2177 - 2187
  • [32] A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer
    Xiaomei Gao
    Yongxiang Tang
    Minfeng Chen
    Jian Li
    Hongling Yin
    Yu Gan
    Xiongbin Zu
    Yi Cai
    Shuo Hu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2177 - 2187
  • [33] Application of [68Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients
    Dadgar, Habibollah
    Emami, Farshad
    Norouzbeigi, Nasim
    Vafaee, Manouchehr Seyedi
    Jafari, Esmail
    Gholamrezanezhad, Ali
    Assadi, Majid
    Ahmadzadehfar, Hojjat
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (04) : 1062 - 1069
  • [34] PSMA Immunohistochemistry Staining in Prostate Cancer Primary Lesion and Comparison with [68Ga]Ga-PSMA-PET/CT Findings
    Isik, Z.
    Guner, G.
    Tuncali, M. Caglar
    Karcaaltincaba, M.
    Akdogan, B.
    Akinci, D.
    Tuncel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S523 - S523
  • [35] 68Ga PSMA PET/CT in Restaging of Prostate Cancer Patients with Biochemical Recurrence
    Seniaray, Nikhil
    Verma, Ritu
    Khanna, Sudhir
    Pruthi, Ankur
    Belho, Ethel
    Mahajan, Harsh
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [36] Superscan Appearance of 68Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
    Koc, Zehra Pinar
    Ozcan, Pinar Pelin
    Ercolak, Vehbi
    Reyhan, Mehmet
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2022, 31 (01) : 60 - 62
  • [37] HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer
    Pozzo, Lorena
    Monteiro, Lucilena Rebelo
    Cerci, Juliano Julio
    Fanti, Stefano
    Negro, Antonella
    Trindade, Evelinda
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (01) : 7 - 20
  • [38] Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
    Fassbender, Thomas Franz
    Schiller, Florian
    Zamboglou, Constantinos
    Drendel, Vanessa
    Kiefer, Selina
    Jilg, Cordula A.
    Grosu, Anca-Ligia
    Mix, Michael
    EJNMMI RESEARCH, 2020, 10 (01)
  • [39] Impact of uptake time on image quality of [68Ga]Ga-PSMA-11 PET/CT
    van der Sar, Esmee C. A.
    Viol, Sebastiaan L. Meyer
    Braat, Arthur J. A. T.
    van Rooij, Rob
    Lam, Marnix G. E. H.
    de Jong, Hugo W. A. M.
    de Keizer, Bart
    MEDICAL PHYSICS, 2023, 50 (12) : 7619 - 7628
  • [40] The impact of (68Ga)-Ga-PSMA-11 PET/CT in primary staging of prostate cancer
    Weitzer, F.
    Pernthaler, B.
    Plhak, E.
    Riedl, R.
    Aigner, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S458 - S458